[Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000787:Angina Pectoris / Q000503:physiopathology; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D001792:Blood Platelets / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006454:Hemoglobins / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012083:Renin / Q000097:blood; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology* / Q000517:prevention & control; D013564:Sympathetic Nervous System / Q000187:drug effects; D013963:Thyroid Hormones / Q000097:blood
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D006454:Hemoglobins; D011943:Receptors, Adrenergic, beta; D013963:Thyroid Hormones; D012083:Renin
Symptômes et complications cardio-vasculaires au sevrage du traitement bêta-bloquant. Implications pratiques.